VERKAZIA

Peak

cyclosporine

NDAOPHTHALMICEMULSION
Approved
Jun 2021
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
20

Mechanism of Action

Calcineurin Inhibitors

Pharmacologic Class:

Calcineurin Inhibitor Immunosuppressant

Clinical Trials (5)

NCT06837259Phase 1Completed

A Study to Learn if Study Medicines Called Cyclosporine and Clarithromycin Affect How the Body Processes the Other Study Medicine Called PF-07328948 in Healthy Adults

Started Mar 2025
26 enrolled
Healthy Adults
NCT05946772Phase 2Recruiting

Cyclosporine In Takotsubo Syndrome

Started Feb 2025
204 enrolled
Takotsubo Cardiomyopathy
NCT06541678Phase 1Completed

A Study to Learn if the Study Medicines Called Itraconazole and Cyclosporine Change How the Body Processes the Other Study Medicine Called Danuglipron in Healthy Adults.

Started Dec 2024
16 enrolled
Healthy
NCT05745701Phase 1Completed

A Drug-Drug Interaction Study to Examine the Impact of Itraconazole and Cyclosporine on PF-07081532 Pharmacokinetics in Overweight or Obese Adults

Started Feb 2023
16 enrolled
Healthy
NCT05573230Phase 1Completed

A Drug Interaction Study of Cyclosporine and LY3502970 in Healthy Participants

Started Oct 2022
32 enrolled
Healthy

Loss of Exclusivity

LOE Date
Jun 2, 2029
39 months away
Patent Expiry
Jun 2, 2029
Exclusivity Expiry
Jun 23, 2028

Patent Records (5)

Patent #ExpiryTypeUse Code
8524779
Jan 27, 2026Expired
Product
7973081
Jan 27, 2026Expired
Product
9220694
Jan 27, 2026Expired
Product
9956289
Jan 27, 2026Expired
Product
11612658
Jan 27, 2026Expired
U-3560